Detected ·
Protuoso Biosciences
$9.5M—
Protuoso Biosciences raised US$9.5M in a seed round to advance its MUXBODIES™ platform, designed to integrate multiple biological mechanisms into a single therapeutic molecule for complex diseases such as obesity, cardiovascular disease, cancer, and autoimmune disorders. The round was led by Seedscap alongside NSG Ventures, taya ventures, Darwin Ventures, and others.
- Website
- www.protuoso.bio
- Amount
- $9 500 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-23 00:04:58 UTC
- Signal ID
- a2c5276d-c7b0-43df-afd4-af344ce8ee0a
As the API returns it
{
"id": "a2c5276d-c7b0-43df-afd4-af344ce8ee0a",
"created_at": "2026-07-23T00:04:58.753440Z",
"company_name": "Protuoso Biosciences",
"company_website_url": "www.protuoso.bio",
"company_linkedin_url": "https://www.linkedin.com/company/protuoso-bio",
"event_type": "funding",
"funding_amount": 9500000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Protuoso Biosciences raised US$9.5M in a seed round to advance its MUXBODIES™ platform, designed to integrate multiple biological mechanisms into a single therapeutic molecule for complex diseases such as obesity, cardiovascular disease, cancer, and autoimmune disorders. The round was led by Seedscap alongside NSG Ventures, taya ventures, Darwin Ventures, and others.*"
}